Phase II Study of the HDAC Inhibitor Romidepsin in Relapsed Small Cell Lung Cancer (CALGB 30304)

Por Otterson, G.A., Hodgson, L., Pang, H., Vokes, E.E.
Publicado em 2010

Differential specificity for binding of retinoblastoma binding protein 2 to RB, p107, and TATA-binding protein.

Por Kim, Y W, Otterson, G A, Kratzke, R A, Coxon, A B, Kaye, F J
Publicado em 1994

The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro.

Por Alexandrova, N, Niklinski, J, Bliskovsky, V, Otterson, G A, Blake, M, Kaye, F J, Zajac-Kaye, M
Publicado em 1995

Stch encodes the 'ATPase core' of a microsomal stress 70 protein.

Por Otterson, G A, Flynn, G C, Kratzke, R A, Coxon, A, Johnston, P G, Kaye, F J
Publicado em 1994

Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.

Por Khleif, S N, DeGregori, J, Yee, C L, Otterson, G A, Kaye, F J, Nevins, J R, Howley, P M
Publicado em 1996

A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced...

Por Doebele, R. C., Conkling, P., Traynor, A. M., Otterson, G. A., Zhao, Y., Wind, S., Stopfer, P., Kaiser, R., Camidge, D. R.
Publicado em 2012

Noncytotoxic suramin as a chemosensitizer in patients with advanced non-small-cell lung cancer: a phase II study

Por Villalona-Calero, M. A., Otterson, G. A., Wientjes, M. G., Weber, F., Bekaii-Saab, T., Young, D., Murgo, A. J., Jensen, R., Yeh, T.-K., Wei, Y., Zhang, Y., Eng, C., Grever, M., Au, J. L.-S.
Publicado em 2008